Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Inspire Pharmaceuticals, Inc. (MM) (ISPH)
Inspire Pharmaceuticals, Inc. (MM) (ISPH) Actualités

ISPH

Inspire Pharmaceuticals, Inc. (MM) (ISPH)

Inspire Pharmaceuticals, Inc. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:ISPH

1 2 3 4 5 6 7 8 9 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
17/05/2011	12h00	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
17/05/2011	00h24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
16/05/2011	22h41	Edgar (US Regulatory)	Termination of Registration of a Class of Security under Section 12(g) (15-12G)	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
16/05/2011	22h09	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
16/05/2011	19h33	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
16/05/2011	17h40	Edgar (US Regulatory)	Post-Effective Amendment to Registration Statement (POS AM)	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
16/05/2011	17h39	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
16/05/2011	15h33	Edgar (US Regulatory)	(25-NSE)	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
13/05/2011	21h39	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (SC 14D9/A)	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
13/05/2011	16h54	Edgar (US Regulatory)	Amended tender offer statement by Third Party (SC TO-T/A)	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
13/05/2011	15h38	Dow Jones News	Merck Gets Warm Tender Reception In $430 Million Inspire Purchase	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
10/05/2011	18h40	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
10/05/2011	12h30	Business Wire	Inspire Reports First Quarter 2011 Financial Results	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
29/04/2011	14h30	Zacks	Merck Tops on Lower Costs - Analyst Blog	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
28/04/2011	14h30	Business Wire	Merck and Inspire Announce Expiration of Hart-Scott-Rodino Act Waiting Period Relating to Tender Offer for Shares of Inspire	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
26/04/2011	16h30	Zacks	Merck: Earnings Preview - Analyst Blog	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
22/04/2011	13h44	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
22/04/2011	12h30	Business Wire	Inspire Postpones Annual Meeting of Stockholders Due to Recently Announced Tender Offer	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
15/04/2011	22h13	Edgar (US Regulatory)	Written communication relating to an issuer or third party (SC TO-C)	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
15/04/2011	21h07	Edgar (US Regulatory)	Written communication by the subject company relating to a third party tender offer (SC14D9C)	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
15/04/2011	15h05	Edgar (US Regulatory)	Statement of Ownership: Solicitation (SC 14D9)	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
15/04/2011	15h01	Business Wire	Merck Commences Tender Offer for all Outstanding Shares of Inspire Pharmaceuticals, Inc.	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
15/04/2011	14h51	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
15/04/2011	14h51	Edgar (US Regulatory)	Tender offer statement by Third Party (SC TO-T)	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
08/04/2011	16h06	Business Wire	The Law Offices of Vincent Wong Announce an Investigation into Possible Breaches of Fiduciary Duty by the Board of Inspire Ph...	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
08/04/2011	12h03	Edgar (US Regulatory)	Amended Securities Registration (section 12(b)) (8-A12B/A)	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
07/04/2011	22h11	Business Wire	Faruqi & Faruqi, LLP Announces Shareholder Investigation Related to the Acquisition of Inspire Pharmaceuticals, Inc. - ISPH	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
07/04/2011	21h36	Business Wire	The Law Firm of Weiss & Lurie Investigates the Acquisition of Inspire Pharmaceuticals, Inc.	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
07/04/2011	05h30	Business Wire	Law Office of Brodsky & Smith, LLC Announces Investigation of Inspire Pharmaceuticals, Inc.	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)
07/04/2011	00h09	Business Wire	The Law Office of Abe Shainberg Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Inspire Ph...	NASDAQ:ISPH	Inspire Pharmaceuticals, Inc. (MM)

Showing the most relevant articles for your search:NASDAQ:ISPH

1 2 3 4 5 6 7 8 9 Suivant >>

Estrella Resources

Romania Tf 4% Fb51 Usd

Ares Management

Water Utility & Infrastr...

Investec Bnk 24

Investec Bnk 23

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales